Biogen (BIIB) tops Q1 expectations; Mizuho says MS sales weaker-than-expected
April 25, 2023 7:52 AM
Biogen (NASDAQ: BIIB) shares are moving modestly lower in pre-market Tuesday after the biotech giant reported its first-quarter results.Biogen posted ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
